Cite
The 2012 Briganti nomogram not only predicts lymph node involvement but also disease progression in surgically treated intermediate-risk prostate cancer patients with PSA
MLA
Antonio Benito Porcaro, et al. “The 2012 Briganti Nomogram Not Only Predicts Lymph Node Involvement but Also Disease Progression in Surgically Treated Intermediate-Risk Prostate Cancer Patients with PSA.” International Brazilian Journal of Urology, vol. 50, no. 4, Aug. 2024, pp. 450–58. EBSCOhost, https://doi.org/10.1590/s1677-5538.ibju.2024.0003.
APA
Antonio Benito Porcaro, Andrea Panunzio, Rossella Orlando, Francesca Montanaro, Alberto Baielli, Francesco Artoni, Sebastian Gallina, Alberto Bianchi, Giovanni Mazzucato, Emanuele Serafin, Giulia Marafioti Patuzzo, Alessandro Veccia, Riccardo Rizzetto, Matteo Brunelli, Filippo Migliorini, Riccardo Bertolo, Alessandro Tafuri, Maria Angela Cerruto, & Alessandro Antonelli. (2024). The 2012 Briganti nomogram not only predicts lymph node involvement but also disease progression in surgically treated intermediate-risk prostate cancer patients with PSA. International Brazilian Journal of Urology, 50(4), 450–458. https://doi.org/10.1590/s1677-5538.ibju.2024.0003
Chicago
Antonio Benito Porcaro, Andrea Panunzio, Rossella Orlando, Francesca Montanaro, Alberto Baielli, Francesco Artoni, Sebastian Gallina, et al. 2024. “The 2012 Briganti Nomogram Not Only Predicts Lymph Node Involvement but Also Disease Progression in Surgically Treated Intermediate-Risk Prostate Cancer Patients with PSA.” International Brazilian Journal of Urology 50 (4): 450–58. doi:10.1590/s1677-5538.ibju.2024.0003.